Evidence map›Paper›PMID 21606111›Full record

ArticleThe Journal of physiology2011

Activation of κ opioid receptors increases intrinsic excitability of dentate gyrus granule cells.

Carmel M McDermott, Laura A Schrader

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. The Kappa Opioid Receptor System in Temporal Lobe Epilepsy.Handbook of experimental pharmacology · 2022
    Article
  5. Chronic mild stress alters synaptic plasticity in the nucleus accumbens through GSK3β-dependent modulation of Kv4.2 channels.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment.Progress in neuro-psychopharmacology & biological psychiatry · 2015
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Impaired hippocampus-dependent and facilitated striatum-dependent behaviors in mice lacking the δ opioid receptor.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2013
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Carmel M McDermottDepartment of Cell and Molecular Biology, Tulane University, 6400 Freret St, New Orleans, LA 70118, USA.
Laura A Schrader
Tulane University · US

Funding

SYNAPTIC AND EXTRASYNAPTIC NMDA RECEPTORS AND NEUROPROTECTIVE LIPID SIGNALINGP20RR016816 · NCRR · LSU HEALTH SCIENCES CENTER · PI THOMPSON, HILARY · 2002 to 2011
$20.2M
Mechanisms of K+ Channel Modulation in PlasticityK01MH064620 · NIMH · TULANE UNIVERSITY OF LOUISIANA · PI SCHRADER, LAURA · 2002 to 2007
$839k
NCRR NIH HHS P20 RR016816NCRR NIH HHS P20RR016816NIMH NIH HHS K01 MH064620NIMH NIH HHS MH064620
6 · The paper itself

Abstract

The dentate gyrus of the hippocampus is thought to control information flow into the rest of the hippocampus. Under pathological conditions, such as epilepsy, this protective feature is circumvented and uninhibited activity flows throughout the hippocampus. Many factors can modulate excitability of the dentate gyrus and ultimately, the hippocampus. It is therefore of critical importance to understand the mechanisms involved in regulating excitability in the dentate gyrus. Dynorphin, the endogenous ligand for the kappa (κ) opioid receptor (KOR), is thought to be involved in neuromodulation in the dentate gyrus. Both dynorphin and its receptor are widely expressed in the dentate gyrus and have been implicated in epilepsy and other complex behaviours such as stress-induced deficits in learning and stress-induced depression-like behaviours. Administration of KOR agonists can prevent both the behavioural and electroencephalographic measures of seizures in several different models of epilepsy. Antagonism of the KORs also prevents stress-induced behaviours. This evidence suggests the KORs as possible therapeutic targets for various pathological conditions. In addition, KOR agonists prevent the induction of LTP. Although there are several mechanisms through which dynorphin could mediate these effects, no studies to date investigated the effects of KOR activation on intrinsic membrane properties and cell excitability. We used whole-cell, patch-clamp recordings from acute mouse hippocampus slices to investigate the effect of KOR activation on dentate gyrus granule cell excitability. The agonist U69,593 (U6, 1 μM) resulted in a lower spike threshold, a decreased latency to first spike, an increased spike half-width, and an overall increase in spike number with current injections ranging from 15 to 45 pA. There was also a reduction in the interspike interval (ISI) both early and late in the spike train, with no change in membrane potential or input resistance. Preincubation of the slice with the selective KOR antagonist, nor-binalthorphimine (BNI, 1 μM) inhibited the effect of U6 on the latency to first spike and spike half-width suggesting that these effects are mediated through KORs. The inclusion of GDP-βS (1 mM) in the recording pipette prevented all of the U6 effects, suggesting that all effects are mediated via a G-protein-dependent mechanism. Inclusion of the A-type K+ current blocker, 4-aminopyridine (4-AP, 5 mM) in the pipette also antagonised the effects of U6. Kv4.2 is one of the channel α subunits thought to be responsible for carrying the A-type K+ current. Incubation of hippocampus slices with U6 resulted in a decrease in the Kv4.2 subunit protein at the cell surface. These results are consistent with an increase in cell excitability in response to KOR activation and may reflect new possibilities for additional opioid functions.

Indexed as

4-AminopyridineAction PotentialsAnimalsBenzeneacetamidesDentate GyrusDynorphinsGTP-Binding ProteinsGuanosine DiphosphateMaleMiceMice, 129 StrainNaltrexoneNeuronsPatch-Clamp TechniquesPotassium ChannelsPyrrolidines4-AminopyridineBenzeneacetamidesDynorphinsGTP-Binding Proteinsguanosine 5'-O-(2-thiodiphosphate)Guanosine DiphosphateNaltrexonenorbinaltorphiminePotassium ChannelsPyrrolidinesReceptors, Opioid, kappaThionucleotidesU 69593

Identifiers

PMID21606111
PMCPMC3167115
OpenAlexW2164313305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.